Publications | Lund University Publications

1 – 10 of 27

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=project+exact+ed6cdefe-1309-4010-a1f5-ab576cf320a8&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
next »

2017
Mark Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
Shahim, Pashtun ; Blennow, Kaj ^LU ; Johansson, Per ^LU ; Svensson, Johan ^LU ; Lista, Simone ; Hampel, Harald ; Andersson, Leif Christer and Zetterberg, Henrik ^LU (2017) In NeuroMolecular Medicine
- Contribution to journal › Article
Mark Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Johansson, Per ^LU ; Almqvist, E G ; Wallin, A ; Johansson, J-O ; Andreasson, U ; Blennow, K ; Zetterberg, H and Svensson, J (2017) In PLoS ONE 12(5).
- Contribution to journal › Article
2016
Mark Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease
Horvath, I. ; Jia, X. ; Johansson, Per ^LU ; Wang, C. ; Moskalenko, R. ; Steinau, A. ; Forsgren, L. ; Wågberg, T. ; Svensson, J. and Zetterberg, H. , et al. (2016) In ACS Chemical Neuroscience 7(1). p.34-39
- Contribution to journal › Article
Mark Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
Öhrfelt, Annika ; Johansson, Per ^LU ; Wallin, Anders ; Andreasson, Ulf ; Zetterberg, Henrik ; Blennow, Kaj and Svensson, Johan (2016) In Dementia and Geriatric Cognitive Disorders Extra 6(2). p.94-283
- Contribution to journal › Article
Mark Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Heslegrave, A ; Heywood, Wendy ; Paterson, Ross ; Magdalinou, Nadia ; Svensson, Johan ^LU ; Johansson, Per ^LU ; Öhrfelt, Annika ; Blennow, Kaj ^LU ; Hardy, John and Schott, Jonathan , et al. (2016) In Molecular Neurodegeneration 11. p.1-7
- Contribution to journal › Article
Mark A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
Paterson, R. W. ; Heywood, W. E. ; Heslegrave, A. J. ; Magdalinou, N. K. ; Andreasson, U. ; Sirka, E. ; Bliss, E. ; Slattery, C. F. ; Toombs, J. and Svensson, J. , et al. (2016) In Translational Psychiatry 6(11). p.1-10
- Contribution to journal › Article
2015
Mark Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
Åberg, D. ; Johansson, Per ^LU ; Isgaard, J. ; Wallin, A. ; Johansson, J.-O. ; Andreasson, U. ; Blennow, K. ; Zetterberg, H. ; Åberg, N.D. and Svensson, J. , et al. (2015) In Journal of Alzheimer's Disease 48(3). p.637-646
- Contribution to journal › Article
Mark Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
Johansson, Per ^LU ; Almqvist, E.G. ; Wallin, A. ; Johansson, J.-O. ; Andreasson, U. ; Blennow, K. ; Zetterberg, H. and Svensson, J. (2015) In Neuroscience Letters 609. p.58-62
- Contribution to journal › Article
2014
Mark The amyloid-β degradation pattern in plasma: A possible tool for clinical trials in Alzheimer's disease
Pannee, J. ; Törnqvist, U. ; Westerlund, A. ; Ingelsson, M. ; Lannfelt, L. ; Brinkmalm, G. ; Persson, R. ; Gobom, J. ; Svensson, J. and Johansson, Per ^LU , et al. (2014) In Neuroscience Letters 573. p.7-12
- Contribution to journal › Article
Mark Increased levels of UCHL-1 in cerebrospinal fluid from patients with Alzheimer’s disease.
Johansson, Per ^LU (2014) In Conference paper keystone symposia 20.
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding

« previous
1
2
3
next »

your query:: Remove project: Endocrine and diagnostic aspects of cognitive impairment